Literature DB >> 8425819

On the statistical reliability of letter-chart visual acuity measurements.

A Arditi1, R Cagenello.   

Abstract

PURPOSE: To determine boundary values of test-retest reliability and sensitivity to acuity change that are unlikely to be exceeded in any clinical situation, for a popular visual acuity chart (Lighthouse/ETDRS) with three scoring methods; to discuss general methodological issues associated with statistical accuracy of optotype chart testing; and to link measures of test reliability to measures of sensitivity to change.
METHODS: Five highly practiced subjects were tested using a computer-controlled acuity testing system in a procedure designed to reduce measurement error. Subjects read the computerized chart 156 times, yielding a sample of 78 test-retest comparisons.
RESULTS: Under conditions likely to minimize variability, visual acuity may, with 95% confidence, be ascertained only within +/- 0.1 log units, using this chart with the recommended letter-by-letter scoring. Detecting a significant change in visual acuity requires about +/- 0.14 log units for the same degree of confidence.
CONCLUSIONS: These measurements may be viewed as approaching the upper limit of reliability of this letter chart. Reliability probably is considerably less in typical usage.

Mesh:

Year:  1993        PMID: 8425819

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  71 in total

1.  The development of a "reduced logMAR" visual acuity chart for use in routine clinical practice.

Authors:  D A Rosser; D A Laidlaw; I E Murdoch
Journal:  Br J Ophthalmol       Date:  2001-04       Impact factor: 4.638

2.  Relation between perceived driving disability and scores of vision screening tests.

Authors:  L J van Rijn; H Wilhelm; M Emesz; R Kaper; S Heine; S Nitsch; G Grabner; H J Völker-Dieben
Journal:  Br J Ophthalmol       Date:  2002-11       Impact factor: 4.638

3.  The usefulness of Vistech and FACT contrast sensitivity charts for cataract and refractive surgery outcomes research.

Authors:  K Pesudovs; C A Hazel; R M L Doran; D B Elliott
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

4.  Reliability of a standardized reading chart system: variance component analysis, test-retest and inter-chart reliability.

Authors:  Eva Stifter; Franz König; Thomas Lang; Peter Bauer; Sibylla Richter-Müksch; Michaela Velikay-Parel; Wolfgang Radner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-10       Impact factor: 3.117

5.  Development of a clinically feasible logMAR alternative to the Snellen chart: performance of the "compact reduced logMAR" visual acuity chart in amblyopic children.

Authors:  D A H Laidlaw; A Abbott; D A Rosser
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

6.  Reliability of acuities determined with the sweep visual evoked potential (sVEP).

Authors:  William H Ridder; Anna Tong; Theresa Floresca
Journal:  Doc Ophthalmol       Date:  2012-01-20       Impact factor: 2.379

7.  Measurement of stray light and glare: comparison of Nyktotest, Mesotest, stray light meter, and computer implemented stray light meter.

Authors:  L J van Rijn; C Nischler; D Gamer; L Franssen; G de Wit; R Kaper; D Vonhoff; G Grabner; H Wilhelm; H J Völker-Dieben; T J T P van den Berg
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

8.  Defining real change in prism-cover test measurements.

Authors:  Jonathan M Holmes; David A Leske; George G Hohberger
Journal:  Am J Ophthalmol       Date:  2007-11-28       Impact factor: 5.258

9.  A new method of extrapolating the sweep pattern visual evoked potential acuity.

Authors:  Peng Zhou; Ming-Wei Zhao; Xiao-Xin Li; Xiao-Feng Hu; Xi Wu; Lan-Jun Niu; Wen-Zhen Yu; Xiu-Lan Xu
Journal:  Doc Ophthalmol       Date:  2007-10-31       Impact factor: 2.379

10.  Long term visual outcome in amblyopia treatment.

Authors:  J Ohlsson; M Baumann; J Sjöstrand; M Abrahamsson
Journal:  Br J Ophthalmol       Date:  2002-10       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.